Bioqual, Inc.
BIOQ · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -15.5% | -16.8% | 23.1% | – |
| Gross Profit | $0 | -$0 | $0 | -$0 |
| % Margin | 8.9% | -42.4% | 19.5% | -1% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 12.1% | 4.1% | 13.4% | -10.8% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -2.5% | -0.8% | 6.7% | -10.6% |
| EPS Diluted | -0.28 | -0.11 | 1.05 | -1.36 |
| % Growth | -154.5% | -110.5% | 177.2% | – |
| Operating Cash Flow | – | $0 | $0 | -$0 |
| Capital Expenditures | – | -$0 | -$0 | -$0 |
| Free Cash Flow | – | $0 | $0 | -$0 |